Skip to content
Research Triangle Regional Partnership
  • Our Region
    • The Triangle
    • Our Counties
    • Talent
    • International
  • Do Business Here
    • Incentives & Grants
    • Investment
    • Startup Ecosystem
    • Featured Sites
  • Target Industries
    • Advanced Manufacturing
    • AgTech
    • CleanTech
      • EV & Battery Tech
    • Life Sciences
      • Gene & Cell Therapy
      • Bioeconomy
    • Technology
      • Cybersecurity
      • Defense Technology
      • Fintech
  • Newsroom
  • About Us
  • Events
  • Contact
  • Select Language
    • en_USEnglish
    • es_ESEspañol
    • fr_FRFrançais
    • de_DEDeutsch
    • it_ITItaliano
    • pl_PLPolski
    • sv_SESvenska
    • fiSuomi
    • da_DKDansk
    • he_ILעִבְרִית
    • zh_CNChinese
    • zh_TW繁體中文
    • ko_KR한국어
    • ja日本語

Gene Therapy

Gene therapy startup raises $55M, plans to add jobs in Triangle

Date Published: December 16, 2020
DURHAM – Atsena Therapeutics, a gene therapy startup backed by Durham-based Hatteras Ventures, has $55 million in new funding and…

Gene editing firm Locus Biosciences adds another $7M to its 2020 cash haul

Date Published: November 9, 2020
MORRISVILLE – Gene editing startup Locus Biosciences has landed another $7 million in new cash, adding to a year that…

Inside the $4B AskBio deal, the third largest buyout ever for an NC bioscience firm

Date Published: October 27, 2020
RESEARCH TRIANGLE PARK – Asklepios BioPharmaceutical (AskBio), a pioneering gene therapy company born in Chapel Hill 19 years ago and…

Gene editing shows promise as tool to fight neuro disorder in babies, UNC study finds

Date Published: October 23, 2020
CHAPEL HILL – Babies born with a faulty maternal copy of the UBE3A gene will develop Angelman syndrome, a severe…
Durham Bulls stadium on a sunny afternoon. Crew members are removing rain tarps from the field.

Hatteras, one of the Triangle’s most important biotech investors, raises more than $137M

Date Published: October 16, 2020
Hatteras Venture Partners, one of the Triangle’s most important biotechnology investors, has raised more $137 million for its newest fund,…

Triangle gene editing firm Locus lands $77M to support new antibacterial treatment

Date Published: October 1, 2020
RESEARCH TRIANGLE PARK – Morrisville-based Locus Biosciences just got a $77 million shot in the arm to develop its new…

Durham firm extends cancer-focused collaboration with a global pharma

Date Published: September 18, 2020
A Triangle gene therapy company is adding more cancer targets to its sights through a partnership with a global pharmaceutical…

Backstory: A look at RTP’s growing gene therapy hub as startup brings 200+ $102,000 jobs to Durham

Date Published: August 12, 2020
RESEARCH TRIANGLE PARK – A young Boston-area gene therapy company, Beam Therapeutics, has joined a cluster of gene and cell…

Beam Therapeutics to build $83M manufacturing facility in RTP, create hundreds of jobs

Date Published: August 12, 2020
RALEIGH — Beam Therapeutics, a Boston-based biotechnology company developing precision medicines through DNA base editing, plans to build a $83…

Contact Us

Send us an email to learn more about the Research Triangle Region.

Ryan Combs Executive Director, Research Triangle Regional Partnership Email rcombs@researchtriangle.org Email Research Triangle, North Carolina
A Special Thank You To Our Corporate Partners
Delta
Official Airline of the RTRP
Duke Energy
©2025 Research Triangle Regional Partnership
  • LinkedIn
  • YouTube
  • Accessibility
  • Privacy Policy
  • Sitemap